人工心臟瓣膜市场：依地点类型、依瓣膜类型、依最终用户、按地区

人造心臟瓣膜市场预计2024年为132.1亿美元，预计到2031年将达到282.9亿美元，2024年至2031年的年复合成长率（CAGR）为11.5%。

2024 年按地区分類的人工心臟瓣膜市场占有率(%)

由于瓣膜性心臟病的盛行率不断上升以及瓣膜置换手术的数量不断增加，人造心臟瓣膜市场在过去几年中经历了稳定增长。人工心臟瓣膜有助于替换无法正常运作的受损心臟瓣膜。老化、吸烟、肥胖和糖尿病等危险因子显着增加了患有二尖瓣瓣膜闭锁不全、主动脉瓣膜闭锁不全和狭窄等心臟瓣膜疾病的患者数量。此外，从机械瓣膜到生物瓣膜的瓣膜设计技术进步以及医疗保健成本的增加也促进了全球人造心臟瓣膜市场的成长。然而，高昂的治疗费用仍然是阻碍更广泛普及的主要问题。

市场动态：

主要国家老年人口的增加以及瓣膜性心臟病负担的增加是人造心臟瓣膜市场的主要成长动力。据估计，光在美国超过 1,600 万人患有瓣膜性心臟病。肥胖和糖尿病是瓣膜性心臟病发展的主要危险因素，其盛行率的增加正在补充市场的成长。此外，采用技术先进的微创经导管心臟瓣膜取代传统的心臟直视手术逐渐普及，从而增加了市场收益。然而，与瓣膜置换手术相关的高昂费用限制了其普及，特别是在发展中地区。新产品核可的严格监管指南也对市场产生负面影响。然而，持续研发以开发价格实惠的设备和增强技术为人工心臟瓣膜製造商在未来几年带来了重大机会。

本研究的主要特点

• 本报告详细分析了全球人工心臟瓣膜市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
• 它还阐明了不同细分市场的潜在收益成长机会，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球人工心臟瓣膜市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球人工心臟瓣膜市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球人工心臟瓣膜市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件

第二章 市场概况

• 报告说明
  • 市场定义和范围
• 执行摘要
• 市场机会蓝图

第 3 章主要见解

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• PEST分析
• 波特分析
• 技术进步
• 合併、收购和合作场景
• 最近的产品核可
• 确定每个地区的主要参与企业
• 监管场景
• 价格分析
• COVID-19 影响分析
• 流行病学
• 各国医疗费用支出
• 赎回场景
• 经销商状况
• 品牌映射
• 比赛简介
• 企业定位分析
• 热图分析

第四章全球人工心臟瓣膜市场，依地点类型，2019-2031

• 介绍
• 主动脉瓣
• 二尖瓣
• 其他的

第5章2019-2031年全球人工心臟瓣膜市场（依瓣膜类型）

• 介绍
• 机械阀
• 组织瓣膜
• 经导管瓣膜

第六章 全球人工心臟瓣膜市场，依最终使用者划分，2019-2031 年

• 介绍
• 医院
• 门诊手术中心
• 导管检测室
• 其他的

第七章2019-2031年全球人工心臟瓣膜市场（按地区）

• 介绍
• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 东南亚国协
• 其他亚太地区
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中东
• 波湾合作理事会
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第八章 竞争格局

第九章公司简介-全球人工心臟瓣膜市场

• Edwards Lifesciences Corporation
• 最新动态/更新
• Medtronic plc.
• Boston Scientific Corporation
• Abbott Laboratories
• LivaNova PLC
• CryoLife Inc.
• Braile Biomedica
• Colibri Heart Valve LLC
• JenaValve Technology Inc.
• TTK Healthcare Limited
• Lepu Medical Technology Co. Ltd
• Foldax, Inc.
• Symetis SA
• On-X Life Technologies
• Braile Biomedica

第10章 盛衰

• 繁荣与衰落
• 综合机会图

第十一章 参考文献与调查方法

• 参考
• 调查方法

The prosthetic heart valve market is estimated to be valued at USD 13.21 Bn in 2024 and is expected to reach USD 28.29 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.

Prosthetic Heart Valve Market Share (%), By Region, 2024

The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics:

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global prosthetic heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market

Market Segmentation

• Valve Type:
  • Mechanical Valves
  • Tissue Valves
  • Transcatheter Valves
• Position Type:
  • Aortic Valve
  • Mitral Valve
  • Others
• End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Catheterization Laboratory
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Edwards Lifesciences Corporation
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Position Type
  • Market Snapshot, By Valve Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Market Scenario - Conservative, Likely, Opportunistic
• Market Opportunity Map

3. Key Insights

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Pest Analysis
• Porters Analysis
• Technological Advancements
• Merger, Acquisition and Collaboration Scenario
• Recent Product Approvals
• Identification of Key Players in Each Region
• Regulatory Scenario
• Pricing Analysis
• COVID-19 Impact Analysis
• Epidemiology
• Healthcare Spending, by Country
• Reimbursement Scenario
• Distributors Landscape
• Brand Mapping
• Competitive Snapshot
• Company Positioning Analysis
• Heat Map Analysis

4. Global Prosthetic Heart Valve Market, By Position Type, 2019 - 2031 (US$ Billion)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2020 - 2031
  • Segment Trends
• Aortic Valve, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Mitral Valve, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Others, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Prosthetic Heart Valve Market, By Valve Type, 2019 - 2031 (US$ Billion)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2020 - 2031
  • Segment Trends
• Mechanical Valves, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Tissue Valves, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Transcatheter Valves, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Prosthetic Heart Valve Market, By End User, 2019 - 2031 (US$ Billion)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031
  • Market Y-o-Y Growth Comparison (%), 2020 - 2031
  • Segment Trends
• Hospitals, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Ambulatory Surgical Centers, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Catheterization Laboratory, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)
• Others, 2019 - 2031(US$ Billion)
  • Introduction
  • Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Prosthetic Heart Valve Market, By Region, 2019 - 2031 (US$ Billion)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
  • Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest Of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
• China
• India
• Japan
• Australia
• South Korea
• Asean
• Rest Of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
• GCC
• Israel
• Rest Of The Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Position Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Valve Type, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
• South Africa
• North Africa
• Central Africa

8. Competitive Landscape

• Competitive Snapshot
• What Market Participants are Saying?
• Competitive Dashboard
• Company Market Share Analysis, 2024 - Global

9. Company Profiles - Global Prosthetic Heart Valve Market

• Edwards Lifesciences Corporation*
  • Company Overview
  • Product/Service Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategic Overview
• Medtronic plc.
• Boston Scientific Corporation
• Abbott Laboratories
• LivaNova PLC
• CryoLife Inc.
• Braile Biomedica
• Colibri Heart Valve LLC
• JenaValve Technology Inc.
• TTK Healthcare Limited
• Lepu Medical Technology Co. Ltd
• Foldax, Inc.
• Symetis SA
• On-X Life Technologies
• Braile Biomedica

10. Wheel of Fortune

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact